Evidence map›Paper›PMID 42528646›Full record

ArticleFrontiers in endocrinology2026

Differences in quantitative 99mTc-MIBI SPECT/CT parameters between parathyroid adenoma and hyperplasia in secondary hyperparathyroidism.

Yuhua Wang, Ye Liu, Yahong Long, Na Li, Wanchun Zhang, Haiyan Liu

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuhua WangDepartment of Nuclear Medicine, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Ye LiuDepartment of Nuclear Medicine, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Yahong LongDepartment of Nuclear Medicine, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Na LiDepartment of Nuclear Medicine, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Wanchun ZhangDepartment of Nuclear Medicine, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Haiyan LiuDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this retrospective study was to investigate the differences in early- and delayed-phase maximum standardized uptake value (SUVmax) and lesion volume on Materials and methods: A total of 111 patients with stage 5 chronic kidney disease (CKD5) undergoing hemodialysis were enrolled in this study. All patients underwent preoperative Results: After adjustment for within-patient clustering, PA lesions showed significantly higher early-phase SUVmax ( Conclusion: Lesion volume is a major determinant of

Indexed as

AdenomaHyperparathyroidism, SecondaryHyperplasiaParathyroid GlandsParathyroid NeoplasmsSingle Photon Emission Computed Tomography Computed TomographyTechnetium Tc 99m SestamibiAdultAgedFemaleHumansMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesROC CurveRadiopharmaceuticalsTechnetium Tc 99m Sestamibiparathyroid adenomaparathyroid hyperplasiasecondary hyperparathyroidismSPECT/CTstandardized uptake value

Identifiers

PMID42528646
PMCPMC13414890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.